Vitrolife AB

27
Strong Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0011205202
SEK
92.85
2.85 (3.17%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Vitrolife AB Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-4,886.00
674.00
-3,712.00
537.00
459.00
366.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-96.00
-68.00
-119.00
-175.00
-10.00
9.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
635.00
907.00
757.00
636.00
384.00
356.00
Cash Flow from Investing Activities
-302.00
-377.00
-124.00
-144.00
-6,518.00
-20.00
Cash Flow from Financing Activities
-553.00
-286.00
-300.00
-582.00
5,748.00
-26.00
Net Cash Inflow / Outflow
-326.00
273.00
283.00
-51.00
-343.00
284.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-106.00
29.00
-50.00
39.00
42.00
-25.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in SEK Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Vitrolife AB
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(SEK)
Change(%)
Profit Before Tax
-4886
491
-5,377.00
-1095.11%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-96
-203
107.00
52.71%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
635
2627
-1,992.00
-75.83%
Cash Flow from Investing Activities
-302
-1673
1,371.00
81.95%
Cash Flow from Financing Activities
-553
-607
54.00
8.90%
Net Cash Inflow / Outflow
-326
177
-503.00
-284.18%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-106
-170
64.00
37.65%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is -29.99% vs 19.82% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
635.00
907.00
-29.99%